Ind-Swift Ltd.

Financial

	Ind-Swift	Bliss GVS Pharma	Lincoln Pharma
Operational Metrics
Financials
5 yr Average ROE	30.85 %	10.14 %	16.41 %
5yr average Equity Multiplier	-1.62	1.36	1.35
5yr Average Asset Turnover Ratio	0.48	0.7	0.87
5yr Avg Net Profit Margin	-45.85 %	10.24 %	14.05 %
Price to Book	0.0	1.29	2.19
P/E	4.45	16.52	13.7
5yr Avg Cash Conversion Cycle	-212.7 Days	162.62 Days	10.4 Days
Inventory Days	74.98 Days	46.41 Days	41.92 Days
Days Receivable	85.13 Days	188.89 Days	86.41 Days
Days Payable	267.01 Days	68.35 Days	100.81 Days
5yr Average Interest Coverage Ratio	-6.47	19.86	44.62
5yr Avg ROCE	-66.14 %	17.11 %	20.85 %
5yr Avg Operating Profit Margin	-5.79 %	21.12 %	21.16 %
5 yr average Debt to Equity	-2.08	0.14	0.03
5yr CAGR Net Profit	n/a	-10.55 %	8.4 %
5yr Average Return on Assets	-16.74 %	7.4 %	12.15 %
Shareholdings
Promoter Holding	55.58 %	34.97 %	49.53 %
Share Pledged by Promoters	42.81 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.03 %	1.66 %	12.27 %
Change in Mutual Fund Holding (3 Yrs)	0.0	-0.03 %	0.0

Business

	Ind-Swift	Bliss GVS Pharma	Lincoln Pharma
Product Wise Break-Up	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 100.0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Central Nervous System 0 Cardiovascular System 0 Blood and Blood Forming Organs 0 Parasitology 0 Musculo-Skeletal System 0 Genito Urinary System and Sex Hormones 0 Alimentary Tract and Metabolism 0 Respiratory Systems 0 General Anti Infectives 0	Product Wise Break-Up Anti-bacterial 0 Blood and Blood Forming Organs 0 Anti-fungal 16.0 Cardiovascular System 0 Respiratory Systems 0 General Anti Infectives 0 Musculo-Skeletal System 0 Antibiotics 5.0 Genito Urinary System and Sex Hormones 0 Parasitology 0 Active Pharmaceutical Ingredient (API) 0 Alimentary Tract and Metabolism 0 Anti Malarials 43.0 Central Nervous System 0 Anti Inflammatory 7.0 Others 29.0	Product Wise Break-Up Anti-bacterial 0 Blood and Blood Forming Organs 0.6 Anti-fungal, 0 Cardiac Science 2.9 Respiratory Systems 9.8 Anti-Infective 29.2 Musculo-Skeletal System 17.9 Anti-biotic 0 Genito Urinary System and Sex Hormones 1.6 Parasitology 6.9 Active Pharmaceutical Ingredient (API) 0 Alimentary Tract and Metabolism 5.9 Antimalarial 0 Central Nervous System (CNS) 0.5 Anti Inflammatory 0 Others 24.7
Location Wise Break-Up	Location Wise Break-Up Rest of the World 70.86 India 29.14	Location Wise Break-Up Rest of the World 94.76 India 5.24	Location Wise Break-Up Rest of the World 57.44 India 42.56
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-bacterial 32.0 Cardiac Science 28.0 Anti-allergic 15.0 Contract Research & Contract Manufacturing (CRAMS) 6.0 Anti-Retroviral 3.0 Central Nervous System (CNS) 2.0 Anti - Diabetes 2.0 Postmenopausal 1.0 Others 11.0	-	-
Brand Wise Break-Up	Brand Wise Break-Up Clarithromycin 32.0 Fexofenadine 15.0 Atorvastatin 14.0 Clopidogrel 7.0 Contract Research & Contract Manufacturing (CRAMS) 6.0 Eyewear 4.0 Ivabradine 3.0 Nitazoxanide 3.0 Acamprosate 2.0 Nateglinide 2.0 Letrazole 1.0 Others 11.0	-	-

Ind-Swift Ltd.

SIGN UP FOR FREE